Morgan Stanley’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.57M | Buy |
|
|||||
|
2023
Q3 | $284K | Buy |
|
|||||
|
2023
Q2 | $92.9K | Sell |
|
|||||
|
2023
Q1 | $46.2K | Buy |
|
|||||
|
2022
Q4 | $51.3K | Sell |
|
|||||
|
2022
Q3 | $705K | Sell |
|
|||||
|
2022
Q2 | $3.02M | Sell |
|
|||||
|
2022
Q1 | $1.46M | Buy |
|
|||||
|
2021
Q4 | $3.66M | Sell |
|
|||||
|
2021
Q3 | $13.4M | Sell |
|
|||||
|
2021
Q2 | $13.4M | Buy |
|
|||||
|
2021
Q1 | $14.2M | Buy |
|